EY Life Sciences

Key themes from “The Next Frontiers in

Precision Medicine” panel

February 2016
Evolution of precision medicine

One-size-fits-all Precision
therapeutics medicine

Convergence of
Tx, Dx and
Disconnected Connected consumer creating
health care health care new vision of the
super health care
consumer

Sick-care Well-care

Page 2 Presentation title

The next frontiers in precision medicine:
key themes

1
Convergence of therapeutics, diagnostics and
consumerism in the life sciences industry is here to stay.

2 Development of creative commercial strategy

and M&A strategy is imperative to drive success.

3 The scientific and clinical underpinnings of these

convergence plays drive their real value.

4
Strong diligence must be performed to be sure to
cut through all of the hype and choose the real
winners in the space.

Page 3
EY Life Sciences
We work with a broad spectrum of life sciences companies to meet business needs, from
strategy to deal execution.

Our professionals have deep clinical, scientific and

consulting experience in the following areas:

Pharma and Medical Life science Information

Diagnostics
biotech device tools technology
► R&D ► In vitro ► Cardiovascular ► Cell biology ► Health IT
► Drug delivery ► Anatomical path ► GI/urology ► Laboratory animals ► Bioinformatics
► Marketing/brand ► Clinical chem ► Hospital supplies ► Mass spec ► Data analytics
management ► Immunoassay ► Imaging ► Microarray ► Data management
► Medical advisory ► Microbiology ► Neurology ► Microscopy and storage
► Commercial ► Molecular ► Orthopedics ► PCR ► LIMS
► LCM ► Point-of-care ► Patient monitoring ► Proteomics ► Algorithm
► Managed markets development
► In vivo ► Respiratory ► Sample prep
► Specialty pharma ► App development
► Reference/specialty ► Surgical equipment ► Separations
► Distribution labs ► Connected health
► Wound care ► Sequencing

Disease areas

Cardiovascular CNS Dermatology Endocrinology GI Hematology Immunology

Infectious disease Nephrology Obesity Oncology Ophthalmology Orphan Orthopedics

Pain Psychiatry Respiratory Rheumatology Urology Vaccines Women’s health

Page 4
Key contacts

Kristin Ciriello Pothier John L. Babitt

Head of Life Sciences, Parthenon-EY Life Sciences Financial Diligence
Transaction Advisory Services and Medtech Leader
Ernst & Young LLP Transaction Advisory Services,
+1 617 549 2779 Ernst & Young LLP
kristin.pothier@ey.com +1 212 773 0912
john.babitt@ey.com

Scott Palmer Mahala Burn

Precision Medicine Leader, Parthenon-EY Life Sciences Practice Director, Parthenon-EY
Transactions Advisory Services Transaction Advisory Services,
Ernst & Young LLP Ernst & Young LLP
+1 415 894 8863 +1 617 478 7023
scott.palmer@ey.com mahala.burn@parthenon.ey.com

Page 5
EY | Assurance | Tax | Transactions | Advisory
About EY
EY is a global leader in assurance, tax, transaction and advisory
services. The insights and quality services we deliver help build trust
and confidence in the capital markets and in economies the world
over. We develop outstanding leaders who team to deliver on our
promises to all of our stakeholders. In so doing, we play a critical role
in building a better working world for our people, for our clients and for
our communities.

EY refers to the global organization and may refer to one or more of

the member firms of Ernst & Young Global Limited, each of which is a
separate legal entity. Ernst & Young Global Limited, a UK company
limited by guarantee, does not provide services to clients. For more
information about our organization, please visit ey.com.

Ernst & Young LLP is a client-serving member firm of Ernst & Young
Global Limited operating in the US.

© 2016 Ernst & Young LLP.

All Rights Reserved.

ED None

This material has been prepared for general informational purposes

only and is not intended to be relied upon as accounting, tax or other
professional advice. Please refer to your advisors for specific advice.

ey.com